APA
DARE icon

American Portfolios Advisors’s Dare Bioscience DARE Stock Holding History

American Portfolios Advisors’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1K Hold
83
– – ﹤0.01% 3272
2022
Q2 		$1.23K Hold
83
– – ﹤0.01% 3235
2022
Q1 		$1.49K Hold
83
– – ﹤0.01% 3288
2021
Q4 		$2K Hold
83
– – ﹤0.01% 3171
2021
Q3 		$1.67K Hold
83
– – ﹤0.01% 3204
2021
Q2 		$1.89K Buy
+83
New +$1.42K ﹤0.01% 3159

Other funds holding DARE

FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SAM
Soviero Asset Management New York $200M AUM 134.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Portfolios Advisors's DARE Position: Q3 2022 in Review

American Portfolios Advisors held its Dare Bioscience (DARE) position steady in Q3 2022 at 83 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #3272.

American Portfolios Advisors first reported a position in DARE in Q2 2021 and has held it in 6 quarters since. The position peaked at $2K in Q4 2021. 31 funds tracked by Wall St. Rank hold DARE as of Q3 2022.

  • American Portfolios Advisors held 83 shares of Dare Bioscience worth $1K as of Q3 2022.
  • American Portfolios Advisors left its Dare Bioscience share count unchanged in Q3 2022.
  • Dare Bioscience made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3272 holding.
  • American Portfolios Advisors first reported a position in Dare Bioscience in Q2 2021 and has held it in 6 quarters since.
  • American Portfolios Advisors's Dare Bioscience position peaked at $2K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.